His primary areas of study are Microbiology, Escherichia coli, Genetics, Antibiotic resistance and Plasmid. Michael R. Mulvey studies Microbiology, namely Multiple drug resistance. The Escherichia coli study combines topics in areas such as Molecular epidemiology and Drug resistance.
The various areas that Michael R. Mulvey examines in his Antibiotic resistance study include Biotechnology, Genome and Phylogenetic tree. In his study, Complete sequence, Cloning, Molecular cloning and Complementation is inextricably linked to Transposable element, which falls within the broad field of Plasmid. His studies in Virology integrate themes in fields like Methicillin-resistant Staphylococcus aureus and Staphylococcus aureus.
His scientific interests lie mostly in Microbiology, Antibiotic resistance, Escherichia coli, Plasmid and Multiple drug resistance. A large part of his Microbiology studies is devoted to Drug resistance. As a part of the same scientific family, Michael R. Mulvey mostly works in the field of Antibiotic resistance, focusing on Antimicrobial and, on occasion, Penicillin.
His study in Escherichia coli is interdisciplinary in nature, drawing from both Molecular epidemiology and Cephalosporin. His studies deal with areas such as Replicon, Antibacterial agent, Intensive care and Genotype as well as Multiple drug resistance. Michael R. Mulvey works mostly in the field of Salmonella enterica, limiting it down to concerns involving Serotype and, occasionally, Streptococcus pneumoniae.
Michael R. Mulvey mainly focuses on Microbiology, Antibiotic resistance, Escherichia coli, Colistin and Drug resistance. His Microbiology research integrates issues from Plasmid and Klebsiella pneumoniae. Michael R. Mulvey works mostly in the field of Plasmid, limiting it down to topics relating to Multiple drug resistance and, in certain cases, Horizontal gene transfer, Feces and Ceftiofur, as a part of the same area of interest.
His work deals with themes such as Ciprofloxacin, Antimicrobial, Salmonella and Carbapenem, which intersect with Antibiotic resistance. His Escherichia coli research focuses on Whole genome sequencing and how it connects with Mobile genetic elements, Beef cattle, Gene family and Cephalosporin Resistance. Michael R. Mulvey interconnects Tigecycline, Internal medicine, Ceftolozane and Tazobactam in the investigation of issues within Colistin.
His primary scientific interests are in Microbiology, Colistin, Tigecycline, Tazobactam and Ceftolozane. Microbiology is closely attributed to Klebsiella pneumoniae in his research. Michael R. Mulvey has included themes like Plasmid, Amikacin, Hospital admission, Sequence and Rectal swab in his Klebsiella pneumoniae study.
His research investigates the connection with Colistin and areas like Broth microdilution which intersect with concerns in Meropenem and Multilocus sequence typing. His Tigecycline research focuses on Ertapenem and how it relates to Telavancin and Internal medicine. His Tazobactam study integrates concerns from other disciplines, such as Methicillin-resistant Staphylococcus aureus and Ceftobiprole.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Comprehensive Antibiotic Resistance Database
Andrew G. McArthur;Nicholas Waglechner;Fazmin Nizam;Austin Yan.
Antimicrobial Agents and Chemotherapy (2013)
Multiplex PCR for the detection of tetracycline resistant genes.
L.-K. Ng;I. Martin;M. Alfa;M. Mulvey.
Molecular and Cellular Probes (2001)
Complete Nucleotide Sequence of a 43-Kilobase Genomic Island Associated with the Multidrug Resistance Region of Salmonella enterica Serovar Typhimurium DT104 and Its Identification in Phage Type DT120 and Serovar Agona
David Boyd;Geoffrey A. Peters;Axel Cloeckaert;Karim Sidi Boumedine.
Journal of Bacteriology (2001)
Complete Nucleotide Sequence of a 92-Kilobase Plasmid Harboring the CTX-M-15 Extended-Spectrum Beta-Lactamase Involved in an Outbreak in Long-Term-Care Facilities in Toronto, Canada
David A. Boyd;Shaun Tyler;Sara Christianson;Allison McGeer.
Antimicrobial Agents and Chemotherapy (2004)
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains
Olivier Clermont;Hiran Dhanji;Mathew Upton;Tarek Gibreel.
Journal of Antimicrobial Chemotherapy (2009)
Nucleotide sequence of katF of Escherichia coli suggests KatF protein is a novel σ transcription factor
Michael R. Mulvey;Peter C. Loewen.
Nucleic Acids Research (1989)
Health Care-Associated Clostridium difficile Infection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study
Denise Gravel;Mark Miller;Andrew Simor;Geoffrey Taylor.
Clinical Infectious Diseases (2009)
The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria : report from the EUCAST Subcommittee
M J Ellington;O Ekelund;Frank Møller Aarestrup;R Canton.
Clinical Microbiology and Infection (2017)
Development of a Canadian Standardized Protocol for Subtyping Methicillin-Resistant Staphylococcus aureus Using Pulsed-Field Gel Electrophoresis
M. R. Mulvey;L. Chui;J. Ismail;L. Louie.
Journal of Clinical Microbiology (2001)
Health Care-Associated Clostridium difficile Infection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality
Mark Miller;Denise Gravel;Michael Mulvey;Geoffrey Taylor.
Clinical Infectious Diseases (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: